• BT NEWS
• /
• v.16 no.1
• /
• pp.46-51
• /
• 2009

• Proceedings of the Korean Society of Food and Cookery Science Conference
• /
• 1993.11a
• /
• pp.333-347
• /
• 1993

• KSBB Journal
• /
• v.11 no.4
• /
• pp.470-475
• /
• 1996

A white rot fungus as a microbial source producing bioflocculant was isolated from rotted leaves and identified as Pestalotiopsis sp. M01. The flocculating activity and productivity of Pestan produced by Pestalotiopsis sp. KCTC 8637P was determined by using Czapek-Dox medium as the inorganic salt source. The flocculating activity was highest at 3% sucrose and 0.3% $KN0_3$, pH 7, and $25^{\circ}C$, respectively. Whilst, the strain growth was highest at 3% sucrose, 0.3% TEX><$KN0_3$, pH 5, and $25^{\circ}C$, respectively.

• Polymer Science and Technology
• /
• v.15 no.4
• /
• pp.411-421
• /
• 2004

Genomics, proteomics, high through-put 기술 등 다양한 기초생물, 의학, 유기화학 분야의 기술 발전을 통하여 신약의 개발 속도는 최근 들어 급격히 가속도가 붙기 시작하고 있다. 그 결과 신약 후보 물질들의 수가 급증하고 있는 추세이다. 현재는 약 3,000-10,000개 정도의 신약 후보 물질 중 약 5-10개 정도의 물질이 임상 phase Ⅰ에 들어가고, 그 중 약 1개 정도의 신약이 최종적으로 얻어지는 것으로 알려져 있다. 스크린이 된 신약 후보 물질이 실질적인 신약으로 탄생하려면 많은 연구과정을 거쳐야 하는데, 고형 경구제제와 같은 제제 연구가 그 중 중요한 부분의 하나이다.(중략)

• NICE (News & Information for Chemical Engineers)
• /
• v.36 no.3
• /
• pp.312-316
• /
• 2018

• Journal of Life Science
• /
• v.27 no.8
• /
• pp.930-936
• /
• 2017

The flocculating properties of bioflocculant Biopol32 produced by Pseudomonas sp. GP32 were investigated for application in industrial wastewater treatment. The major flocculating substance of bioflocculant Biopol32 was identified as polysaccharide. Many anionic flocculants need a counter ion to induce higher flocculating activity. The flocculating activity of bioflocculant Biopol32 was markedly increased by the addition of cationic ions ($Ca^{2+}$, $Al^{3+}$). The flocculating activity of bioflocculant Biopol32 was the most effective when 7.0 mM $CaCl_2{\cdot}2H_2O$ as coflocculant was added. The flocculating activity on the effect of pH and the temperature of the bioflocculant Biopol32 was compared with anionic commercial flocculant (polyacrylamide) and bioflocculant (zooglan from Zoogloea ramigera). In kaolin suspension, the highest flocculating activity was obtained at the bioflocculant Biopol32 concentration of 1.5 mg/l. A high flocculating activity was observed in the pH range of 5.0 to 8.0. The flocculating activity of bioflocculant Biopol32 was sustained up to $60^{\circ}C$, but decreased rapidly at over $70^{\circ}C$. In the batch culture, the charge density of bioflocculant Biopol32 was compared with flocculating activity. The larger the anionic charge density and apparent viscosity of bioflocculant Biopol32, the higher the flocculating activity. Therefore, we confirmed that the flocculating activity and apparent viscosity of bioflocculant Biopol32 was closely related to the charge density of bioflocculant Biopol32.

• Polymer Science and Technology
• /
• v.20 no.4
• /
• pp.338-346
• /
• 2009

• Bioindustry News
• /
• v.10 no.4
• /
• pp.27-33
• /
• 1997

• KSBB Journal
• /
• v.14 no.3
• /
• pp.297-302
• /
• 1999

The polymeric matrices coated with poly(DL-lactide) were prepared using chitosan derivatives such as chitosan, chitosan hydrochloride, and sulfonated chitosan for application of drug delivery systems. The drug release study using prednisolone as a model drug was performed in the hydrochloride solution at pH 1.2. The release rate of drug was decreased according to the increased content of matrices. The release rate of prednisolone according to the kinds of polymeric matrices coated were decreased in the order to chitosan, sulfonated chitosan, and chitosan hydrochloride. Drug release rate of polymeric matrices coated with poly(DL-lactide) was not only two times slower than noncoated one, but also the burst effect of initial period of drug release was decreased in comparison with noncoated one. From these results, it was expected that these formulations based on the chitosan derivative matrices coasted with poly(DL-lactide) were acceptable drug delivery devices for a sustained-release dosage form of drug.

• Polymer(Korea)
• /
• v.37 no.5
• /
• pp.625-631
• /
• 2013

Mucoadhesive property is the major function as an adhesive for medical devices, and therefore, these days many researches have conducted to develop polymers having this property. Recently, biomimetic technology has been used for developing mucoadhesive polymers. Among many technologies, mussel-inspired approaches have received noticeable attention because of its thread's strong adhesive characteristics. In this study, we synthesized mucoadhesive biomimetic polymers employing catechol structures which are abundant in mussel adhesive proteins, and their structures and molecular weights were characterized by using nuclear magnetic resonance spectroscopy and gel permeation chromatography. To evaluate in vitro mucoadhesive strength, the sheet type of the small intestinal porcine submucosa was prepared. Compared to commercial fibrin glue adhesives, catechol-containing mucoadhesive polymers showed enhanced adhesive strength. The study of adhesive strength with considering diverse factors, such as temperature, pressure, and oxidant amount indicated that mussel-inspired mucoadhesive polymer could be a promising candidate for an adhesive in various biomedical applications.